503.90
price up icon0.06%   0.30
after-market アフターアワーズ: 499.00 -4.90 -0.97%
loading

United Therapeutics Corp (UTHR) 最新ニュース

pulisher
Feb 27, 2026

United Therapeutics Corp. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics - Markets Mojo

Feb 27, 2026
pulisher
Feb 26, 2026

United Therapeutics Corp. Hits New 52-Week High at $537.11 - Markets Mojo

Feb 26, 2026
pulisher
Feb 26, 2026

H.C. Wainwright raises United Therapeutics stock price target to $600 - Investing.com Nigeria

Feb 26, 2026
pulisher
Feb 26, 2026

United Therapeutics Hits Day High with 13% Surge in Strong Intraday Performance - Markets Mojo

Feb 26, 2026
pulisher
Feb 26, 2026

United Therapeutics (NASDAQ:UTHR) Given New $600.00 Price Target at HC Wainwright - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings - Benzinga

Feb 26, 2026
pulisher
Feb 26, 2026

Why United Therapeutics (UTHR) Shares Are Sliding Today - Finviz

Feb 26, 2026
pulisher
Feb 26, 2026

Oppenheimer Raises United Therapeutics (UTHR) Price Target to $6 - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Wells Fargo Raises Price Target for United Therapeutics (UTHR) t - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

MannKind’s Stock Plummets as United Therapeutics Unveils Rival Product - StocksToTrade

Feb 26, 2026
pulisher
Feb 26, 2026

Wells Fargo & Company Issues Positive Forecast for United Therapeutics (NASDAQ:UTHR) Stock Price - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

United Therapeutics Corporation (NASDAQ:UTHR) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 26, 2026
pulisher
Feb 26, 2026

MANNKIND CORP SEC 10-K Report - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

United Therapeutics Q4 Earnings Call Highlights - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

TD Cowen raises United Therapeutics stock price target on growth outlook - Investing.com Nigeria

Feb 26, 2026
pulisher
Feb 25, 2026

BofA raises United Therapeutics stock price target on earnings beat By Investing.com - Investing.com Canada

Feb 25, 2026
pulisher
Feb 25, 2026

MannKind stock plummets after partner United Therapeutics unveils new 'category killer product' - MSN

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics (NASDAQ:UTHR) Director Christopher Causey Sells 1,000 Shares - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics Corp (UTHR) Q4 2025 Earnings Call Highlights: Record Revenue and Promising Innovations - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics Corporation Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 25, 2026
pulisher
Feb 25, 2026

BofA raises United Therapeutics stock price target on earnings beat - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics (UTHR) Plans New Inhaler, Impacting MannKind (MNKD) and Liquidia (LQDA) - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Asianet Newsable

Feb 25, 2026
pulisher
Feb 25, 2026

Earnings call transcript: United Therapeutics beats Q4 2025 EPS estimates By Investing.com - Investing.com Canada

Feb 25, 2026
pulisher
Feb 25, 2026

MannKind stock tumbles 37% on United Therapeutics inhaler news - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates - Nasdaq

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics (UTHR) Stock: Surges on Record $3.18B Revenue and Breakout Tyvaso Growth - CoinCentral

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics Q4 2025 slides: EPS beat drives stock surge - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

MannKind (MNKD) Shares Plummet Amid United Therapeutics Announcement - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics Stock Rises 9% Over Increased Earnings In Q4 - Nasdaq

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics stock hits all-time high at $520.00 - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics Q4 2025 slides: EPS beat drives stock surge By Investing.com - Investing.com UK

Feb 25, 2026
pulisher
Feb 25, 2026

Earnings call transcript: United Therapeutics beats Q4 2025 EPS estimates - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates - Finviz

Feb 25, 2026
pulisher
Feb 25, 2026

UTHR Stock Price and Chart — NASDAQ:UTHR - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics Corp. (NASDAQ:UTHR) Reports Record Annual Revenue Despite Q4 Top-Line Miss - ChartMill

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics Q4 Earnings Beat Expectations - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics (UTHR) Surpasses EPS Expectations in Q4 - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics (UTHR) Reports Record Revenue but Misses Q4 Forecasts - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics: Fourth Quarter Earnings Overview - Bitget

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics: Q4 Earnings Snapshot - marketscreener.com

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics stock falls nearly 5% on revenue miss despite earnings beat - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

UNITED THERAPEUTICS Corp SEC 10-K Report - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

United Therapeutics Corp Q4 Profit Rises - Nasdaq

Feb 25, 2026
pulisher
Feb 24, 2026

Michael Benkowitz Sells 14,440 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan

Feb 24, 2026
pulisher
Feb 24, 2026

United Therapeutics earnings up next: Tyvaso seasonality in focus - Investing.com

Feb 24, 2026
pulisher
Feb 24, 2026

United Therapeutics Set to Announce Q4 Earnings on February 25 - Intellectia AI

Feb 24, 2026
pulisher
Feb 24, 2026

Insights Ahead: United Therapeutics's Quarterly Earnings - Benzinga

Feb 24, 2026
pulisher
Feb 23, 2026

United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For - Finviz

Feb 23, 2026
pulisher
Feb 23, 2026

United Therapeutics Corporation (UTHR) Stock Analysis: Potential Upside of 13.77% Amid Robust Pipeline and Strategic Collaborations - DirectorsTalk Interviews

Feb 23, 2026
pulisher
Feb 23, 2026

United Therapeutics leadership to give March 2 update at TD Cowen - Stock Titan

Feb 23, 2026
pulisher
Feb 20, 2026

Vanguard Group Inc. Lowers Position in United Therapeutics Corporation $UTHR - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance

Feb 20, 2026
pulisher
Feb 19, 2026

Insider Selling: United Therapeutics (NASDAQ:UTHR) EVP Sells 8,300 Shares of Stock - MarketBeat

Feb 19, 2026
pulisher
Feb 19, 2026

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight (2026-02-19) - Seeking Alpha

Feb 19, 2026
pulisher
Feb 19, 2026

AnaptysBio (ANAB) to Release Quarterly Earnings on Thursday - Defense World

Feb 19, 2026
pulisher
Feb 19, 2026

Cabot Corporation (NYSE:CBT) Given Average Rating of “Hold” by Analysts - Defense World

Feb 19, 2026
pulisher
Feb 19, 2026

Vertex Casgevy Rollout Tests Gene Editing Role In Vertex Earnings Story - simplywall.st

Feb 19, 2026
pulisher
Feb 19, 2026

Oppenheimer & Co. Inc. Takes $407,000 Position in BridgeBio Pharma, Inc. $BBIO - Defense World

Feb 19, 2026
pulisher
Feb 19, 2026

Shell Asset Management Co. Decreases Position in United Therapeutics Corporation $UTHR - Defense World

Feb 19, 2026
$14.93
price down icon 2.10%
$132.25
price up icon 1.23%
$26.40
price up icon 0.80%
drug_manufacturers_specialty_generic RGC
$26.23
price down icon 0.23%
drug_manufacturers_specialty_generic RDY
$14.38
price down icon 1.37%
大文字化:     |  ボリューム (24 時間):